Product Liability Reform: SB 684 (1988).
Provides that a product may be unreasonably dangerous only because
Provides that a product may be unreasonably dangerous only because of one or more of the following characteristics: (a) defective construction or composition; (b) defective design; (c) failure to warn or inadequate warning; or (d) nonconformity with an express warranty. Provides that a manufacturer of a product shall not be liable for damage proximately caused by a characteristic of the product’s design if the manufacturer proves that at the time the product left his control: (a) he did not know and, in light of then-existing reasonably available scientific and technological knowledge, could not have known of the design characteristic that caused the damage; (b) he did not know and, in light of then-existing reasonable available scientific and technological knowledge, could not have known of the alternative design identified by the claimant; or (c) the alternative design identified by the claimant was not feasible, in light of then-existing reasonably available scientific and technological knowledge or then-existing economic practicality.
Latest News
View all news
West Virginia AG Candidates Fail to Sign Transparency Oath
ATRA reports neither candidate for West Virginia Attorney General has signed its transparency oath, writes Chris Dickerson for the West Virginia Record.
Trial Lawyers Treat COVID-19 As Another Feather In Their Caps
ATRA President Tiger Joyce writes about trial lawyers’ latest pet project – business interruption lawsuits against insurance companies in the wake of COVID-19.
Transparency On the Back Burner for West Virginia AG Candidates
ATRA reports West Virginia attorney general candidates’ inaction on transparency code pledge.
Utah AG Candidates Vow to Prioritize Transparency by Signing Pledge
ATRA announces two Utah candidates for attorney general signing its AG transparency code pledge.
Trial Lawyers Delight at Prospect of Congress, White House Flip
A Washington controlled by Democrats would be a bonanza for the trial bar, writes W.J. Kennedy for Legal Newsline.
Judge Managing Opioid Lawsuit Under Scrutiny
ATRA President Tiger Joyce dives into controversies surrounding biases of the federal judge overseeing the nation’s opioid MDL for Inside Sources.